Key Insights

Highlights

Treatment Research

3 treatments under study, led by Live Attenuated H1n1 Influenza Vaccine

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01097941Phase 4WithdrawnPrimary

Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children

Showing all 1 trials

Research Network

Common Treatments

  • Live Attenuated H1n1 Influenza Vaccine1
  • Influenza A H1n1 2009 Monovalent Vaccine Influenza A H1n1 Monovalent Vaccine Live1
  • Influenza A H1n1 2009 Monovalent Vaccine1

Active Sponsors

  • National Institutes of Health (NIH)1
  • University of Rochester1

Top Investigators

Activity Timeline